Formulation and evaluation of nasal mucoadhesive microspheres of Sumatriptan succinate

Journal of Microencapsulation

Volumn 26, Issue 8, 2009, Pages 711-721

  Jain, Snehal A ^a   Chauk, Dheeraj S ^a   Mahajan, Hitendra S ^a   Tekade, Avinash R ^a   Gattani, Surendra G ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Microspheres; Mucoadhesion; Nasal delivery; Sumatriptan succinate

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; MICROSPHERE; SUMATRIPTAN SUCCINATE;

ANIMAL TISSUE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; IN VITRO STUDY; MUCOADHESION; NONHUMAN; NOSE MUCOSA; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY DIFFRACTION;

ADHESIVENESS; ADMINISTRATION, INTRANASAL; METHYLCELLULOSE; MICROSPHERES; MIGRAINE DISORDERS; NASAL MUCOSA; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 70449411953     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040802685241     Document Type: Article

References (17)

1. Basak SC, Reddy BM, Mani KP. 2006. Formulation and release behavior of sustained release ambroxol hydrochloride HPMC matrix tablet. Indian J Pharm Sci 68:594-598.
2. Behl CR, Pimplaskar HK, Sileno AP, Xia WJ, Gries WJ, Demeireles JC. 1998. Optimization of systemic nasal drug delivery with pharmaceutical excipients. Adv Drug Deliv Rev 29:117-133.
3. Bhise SB, Rajkumar M. 2007. Controlled nasal delivery of ondansetron HCl. Indian J Pharm Educ Res 41:229-235.
4. Chowdary KPR, Rao YS. 2005. Mucoadhesive microspheres and microcapsules: Current status. Indian J Pharm Sci 67:141-150.
5. Fu-De C, Ming-Shi Y, Ben-Gang Y, Yu-Ling F, Liang W, Peng Y, et al. 2003. Preparation of sustained-release nitrendipine microspheres with eudragit RS and aerosil using quasi-emulsion solvent diffusion method. Int J Pharm 259:103-113.
6. Gavini E, Hegge AB, Rassu G, Sanna V, Testa C, Pirisino G, et al. 2006. Nasal administration of carbamazepine using chitosan microspheres: In vitro/in vivo studies. Int J Pharm 307:9-15.
7. Giovanni FO, Giulia B, Piera DM, Sante M. Spray-drying as a method for microparticulate controlled release systems preparation: Advantagesand limits. I. Water-Soluble drugs. Drug Development and Industrial Pharmacy 2001; 27: 195-204.
8. Hameed MD, Kellaway IW. 1997. Preparation and in vitro characterization of mucoadhesive polymeric microspheres as intra-nasal delivery systems. Eur J Pharm Biopharm 44:53-60.
9. Juan JT, Alfredo GA, Santiago TS, Luis G. 2001. Spray-dried powders as nasal absorption enhancers of cyanocobalamin. Biol Pharm Bull 24:1411-1416.
10. Mahalaxmi R, Kumar S. 2007. Preparation of mucoadhesive microspheres for nasal delivery by spray drying. Indian J Pharm Sci 9:651-657.
11. Martinac A, Filipovic G, Perissutti B, Voinovich D, Pavelic Z. 2005. Spraydried chitosan/ethylcellulose microspheres for nasal drug delivery: Swelling study and evaluation of in vitro drug release properties. J Microencapsulation 22:549-561.
12. Michael IU, Norbert V, Renaat K. 2001. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53:3-22.
13. Pereswetoff-Morath L. 1998. Microspheres as nasal drug delivery systems. Adv Drug Del Rev 29:185-194.
14. Rita JM, Pradip KG, Manish LU, Rayasa SR. 2006. Thermoreversible mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech 7:E1-7.
15. Saraparn H, Vimolmas L, Narueporn S, Garnpimol CR. 2006. Spraydried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer. AAPS PharmSciTech 7:E1-10.
16. Ugwoke M, Agu R, Verbeke N, Kinget R. 2005. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Adv Drug Del Rev 57:1640-1665.
17. Ugwoke MI, Verbeke N, Kinget R. 2001. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53:3-22.